Insights

Target biotech Chameleon Biosciences is a Berkeley-based gene therapy startup focusing on immunomodulatory solutions to enable safer and more effective gene therapies, indicating a market niche in immune-tolerance strategies for genetic disorders.

Strategic funding With total funding of around $14M and revenue under $1M, the company is in a growth phase with available capital for partnerships, pilot studies, and early clinical research collaborations.

Award credibility Recent recognition as Immunomodulatory Solution of the Year and Biotech Breakthrough Award enhances credibility, potentially easing introductions to hospital systems, pharma partners, and grant opportunities.

Leadership growth Addition of Thomas W. Chalberg to the board signals governance and strategic expertise, offering opportunities for credibility in investor discussions and collaboration with senior biotech networks.

Global exposure Operates with a tech stack and cloud-based infrastructure, plus an online presence, suggesting readiness for digital partnerships, remote collaborations, and scalable data management with potential CRO/CMO integrations.

Chameleon Biosciences, Inc. Tech Stack

Chameleon Biosciences, Inc. uses 8 technology products and services including Usercentrics, WordPress, Cookiebot, and more. Explore Chameleon Biosciences, Inc.'s tech stack below.

Usercentrics

Consent Management

WordPress

Content Management System

Cookiebot

Cookie Compliance

GoDaddy Email

Email Hosting

Google Cloud

Infrastructure As A Service

WP Engine

Platform As A Service

Autoptimize

Web Platform Extensions

Gravity Forms

Web Platform Extensions

Chameleon Biosciences, Inc. Email Formats	Example	Percentage
FirstL@chameleonbiosci.com	JohnD@chameleonbiosci.com	100%

Chameleon Biosciences, Inc. Email Formats

Example

Percentage

FirstL@chameleonbiosci.com

JohnD@chameleonbiosci.com

100%

Frequently Asked Questions

What is Chameleon Biosciences, Inc.'s official website and social media links?

Chameleon Biosciences, Inc.'s official website is chameleonbiosci.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Chameleon Biosciences, Inc. generate?

As of September 2026, Chameleon Biosciences, Inc.'s annual revenue is estimated to be <$1M.

What is Chameleon Biosciences, Inc.'s SIC code and NAICS code?

Chameleon Biosciences, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Chameleon Biosciences, Inc. have currently?

As of September 2026, Chameleon Biosciences, Inc. has approximately 2 employees across 1 continents, including Europe. Key team members include Investor: J. L. Explore Chameleon Biosciences, Inc.'s employee directory with LeadIQ.

What industry does Chameleon Biosciences, Inc. belong to?

Chameleon Biosciences, Inc. operates in the Biotechnology Research industry.

What technology does Chameleon Biosciences, Inc. use?

Chameleon Biosciences, Inc.'s tech stack includes Usercentrics, WordPress, Cookiebot, GoDaddy Email, Google Cloud, WP Engine, Autoptimize and Gravity Forms.

What is Chameleon Biosciences, Inc.'s email format?

Chameleon Biosciences, Inc.'s email format typically follows the pattern of FirstL@chameleonbiosci.com. Find more Chameleon Biosciences, Inc. email formats with LeadIQ.

How much funding has Chameleon Biosciences, Inc. raised to date?

As of September 2026, Chameleon Biosciences, Inc. has raised $14M in funding. The last funding round occurred on Nov 01, 2022.

When was Chameleon Biosciences, Inc. founded?

Chameleon Biosciences, Inc. was founded in 2017.

Chameleon Biosciences, Inc.

Q: How many employees does Chameleon Biosciences, Inc. have currently?

Chameleon Biosciences, Inc. has approximately 2 employees.

Q: What industry does Chameleon Biosciences, Inc. belong to?

Chameleon Biosciences, Inc. operates in the Biotechnology Research industry.

Q: What technology does Chameleon Biosciences, Inc. use?

Chameleon Biosciences, Inc.'s tech stack includes RSS, Twemoji, GoDaddy, OpenResty, WordPress.

Q: How much funding has Chameleon Biosciences, Inc. raised to date?

Chameleon Biosciences, Inc. has raised $14M in funding. The last funding round occurred on Nov 01, 2022.

Q: When was Chameleon Biosciences, Inc. founded?

Chameleon Biosciences, Inc. was founded in 2017.

Q: What is Chameleon Biosciences, Inc.'s NAICS code?

Chameleon Biosciences, Inc.'s NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchCalifornia, United States2-10 Employees

Chameleon Biosciences, Inc. is a gene therapy-focused biotechnology company based in Berkeley, California. The firm operates in the biotechnology research sector and aims to address genetic disorders by developing approaches that mitigate immune responses that can limit the effectiveness of gene therapies. Its work targets the challenge of immune activation in patients, with the goal of enabling safer and more effective treatments. The company positions itself as a small, specialized entity in the life sciences ecosystem, steadily advancing its research while based in the Berkeley area. In recent developments, the organization has received industry recognition, including awards highlighting its immunomodulatory approach. A member of its governance team includes Thomas W. Chalberg, who joined the board of directors in early 2022.

Insights

Similar companies to Chameleon Biosciences, Inc.

Alnylam Pharmaceuticals